Stay updated on GEMINI 1 Tolebrutinib Clinical Trial
Sign up to get notified when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.

Latest updates to the GEMINI 1 Tolebrutinib Clinical Trial page
- Check6 days agoChange DetectedAdds a new citation for 'Tolebrutinib liver safety: A detailed overview' by Maxwell et al., expanding the page’s bibliography with author names. The page revision is updated to v3.6.5, while the prior plain language results summary, Sanofi branding, 'Helpful Links Provided by', and the v3.6.4 revision tag are removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision tag, v3.6.4, has been added to replace the previous v3.6.3. This indicates a minor update to the page’s build or documentation without altering substantive content.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.3, indicating a newer version of the document. This update reflects a version-control change rather than a substantive modification to study details.SummaryDifference0.0%

- Check63 days agoChange DetectedAdds a recruitment-status note that the study is no longer enrolling and introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment header formatting and the revision tag.SummaryDifference0.2%

- Check70 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, signaling a software revision on the page. The update does not alter study details or visible content.SummaryDifference0.0%

- Check91 days agoChange DetectedAn updated revision tag from v3.5.3 to v3.5.4 is shown, indicating a minor build/metadata update. There are no changes to the study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to GEMINI 1 Tolebrutinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.